Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 11 |
GO:0005829 | cytosol | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A0A3S7X3W6
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006259 | DNA metabolic process | 4 | 12 |
GO:0006281 | DNA repair | 5 | 12 |
GO:0006289 | nucleotide-excision repair | 6 | 12 |
GO:0006508 | proteolysis | 4 | 12 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0006950 | response to stress | 2 | 12 |
GO:0006974 | DNA damage response | 4 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009056 | catabolic process | 2 | 12 |
GO:0009057 | macromolecule catabolic process | 4 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0010498 | proteasomal protein catabolic process | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 12 |
GO:0030163 | protein catabolic process | 4 | 12 |
GO:0033554 | cellular response to stress | 3 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044248 | cellular catabolic process | 3 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0050896 | response to stimulus | 1 | 12 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 12 |
GO:0051716 | cellular response to stimulus | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 12 |
GO:1901575 | organic substance catabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003677 | DNA binding | 4 | 12 |
GO:0003684 | damaged DNA binding | 5 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005515 | protein binding | 2 | 11 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 4 | 11 |
GO:0032182 | ubiquitin-like protein binding | 3 | 11 |
GO:0043130 | ubiquitin binding | 4 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140030 | modification-dependent protein binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0044877 | protein-containing complex binding | 2 | 1 |
GO:0070628 | proteasome binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.294 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.362 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.276 |
CLV_PCSK_PC1ET2_1 | 27 | 29 | PF00082 | 0.362 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.276 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.307 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.319 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.311 |
DEG_APCC_DBOX_1 | 261 | 269 | PF00400 | 0.338 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.419 |
DEG_SCF_FBW7_1 | 107 | 113 | PF00400 | 0.538 |
DEG_SPOP_SBC_1 | 111 | 115 | PF00917 | 0.697 |
DEG_SPOP_SBC_1 | 142 | 146 | PF00917 | 0.752 |
DOC_CKS1_1 | 107 | 112 | PF01111 | 0.574 |
DOC_CYCLIN_yCln2_LP_2 | 221 | 227 | PF00134 | 0.661 |
DOC_CYCLIN_yCln2_LP_2 | 294 | 300 | PF00134 | 0.537 |
DOC_MAPK_MEF2A_6 | 182 | 189 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 305 | 313 | PF00069 | 0.529 |
DOC_MAPK_NFAT4_5 | 182 | 190 | PF00069 | 0.451 |
DOC_PP1_RVXF_1 | 38 | 44 | PF00149 | 0.556 |
DOC_PP2B_LxvP_1 | 221 | 224 | PF13499 | 0.505 |
DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.603 |
DOC_USP7_MATH_1 | 136 | 140 | PF00917 | 0.691 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.671 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.629 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.525 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.627 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.618 |
DOC_USP7_MATH_1 | 330 | 334 | PF00917 | 0.714 |
DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.700 |
DOC_USP7_MATH_1 | 92 | 96 | PF00917 | 0.706 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.689 |
DOC_USP7_UBL2_3 | 2 | 6 | PF12436 | 0.389 |
DOC_WW_Pin1_4 | 106 | 111 | PF00397 | 0.674 |
DOC_WW_Pin1_4 | 113 | 118 | PF00397 | 0.603 |
DOC_WW_Pin1_4 | 143 | 148 | PF00397 | 0.729 |
DOC_WW_Pin1_4 | 213 | 218 | PF00397 | 0.421 |
DOC_WW_Pin1_4 | 244 | 249 | PF00397 | 0.668 |
DOC_WW_Pin1_4 | 99 | 104 | PF00397 | 0.731 |
LIG_BRCT_BRCA1_1 | 175 | 179 | PF00533 | 0.412 |
LIG_BRCT_BRCA1_1 | 396 | 400 | PF00533 | 0.486 |
LIG_FHA_1 | 107 | 113 | PF00498 | 0.577 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.515 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.497 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.514 |
LIG_FHA_1 | 413 | 419 | PF00498 | 0.618 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.458 |
LIG_FHA_2 | 356 | 362 | PF00498 | 0.588 |
LIG_LIR_Gen_1 | 216 | 226 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 308 | 314 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 201 | 207 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 216 | 221 | PF02991 | 0.594 |
LIG_LIR_Nem_3 | 308 | 313 | PF02991 | 0.465 |
LIG_PTAP_UEV_1 | 137 | 142 | PF05743 | 0.522 |
LIG_SH2_NCK_1 | 300 | 304 | PF00017 | 0.537 |
LIG_SH2_NCK_1 | 34 | 38 | PF00017 | 0.512 |
LIG_SH2_SRC | 34 | 37 | PF00017 | 0.537 |
LIG_SH2_STAT5 | 202 | 205 | PF00017 | 0.502 |
LIG_SH2_STAT5 | 385 | 388 | PF00017 | 0.482 |
LIG_SH3_1 | 72 | 78 | PF00018 | 0.676 |
LIG_SH3_3 | 121 | 127 | PF00018 | 0.705 |
LIG_SH3_3 | 135 | 141 | PF00018 | 0.534 |
LIG_SH3_3 | 323 | 329 | PF00018 | 0.713 |
LIG_SH3_3 | 72 | 78 | PF00018 | 0.629 |
LIG_Sin3_3 | 335 | 342 | PF02671 | 0.525 |
LIG_UBA3_1 | 4 | 11 | PF00899 | 0.492 |
MOD_CK1_1 | 120 | 126 | PF00069 | 0.743 |
MOD_CK1_1 | 156 | 162 | PF00069 | 0.590 |
MOD_CK1_1 | 231 | 237 | PF00069 | 0.680 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.684 |
MOD_CK2_1 | 252 | 258 | PF00069 | 0.682 |
MOD_CK2_1 | 350 | 356 | PF00069 | 0.600 |
MOD_Cter_Amidation | 68 | 71 | PF01082 | 0.263 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.733 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.692 |
MOD_GlcNHglycan | 138 | 141 | PF01048 | 0.570 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.645 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.514 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.602 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.676 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.484 |
MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.664 |
MOD_GlcNHglycan | 352 | 355 | PF01048 | 0.622 |
MOD_GlcNHglycan | 377 | 382 | PF01048 | 0.551 |
MOD_GlcNHglycan | 93 | 97 | PF01048 | 0.669 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.619 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.636 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.668 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.591 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.541 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.604 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.687 |
MOD_N-GLC_1 | 61 | 66 | PF02516 | 0.301 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.736 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.460 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.512 |
MOD_PIKK_1 | 385 | 391 | PF00454 | 0.560 |
MOD_PIKK_1 | 412 | 418 | PF00454 | 0.648 |
MOD_Plk_1 | 342 | 348 | PF00069 | 0.575 |
MOD_Plk_1 | 360 | 366 | PF00069 | 0.496 |
MOD_Plk_1 | 377 | 383 | PF00069 | 0.455 |
MOD_Plk_1 | 48 | 54 | PF00069 | 0.527 |
MOD_Plk_1 | 61 | 67 | PF00069 | 0.497 |
MOD_Plk_4 | 19 | 25 | PF00069 | 0.530 |
MOD_Plk_4 | 309 | 315 | PF00069 | 0.559 |
MOD_Plk_4 | 343 | 349 | PF00069 | 0.687 |
MOD_Plk_4 | 394 | 400 | PF00069 | 0.498 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.483 |
MOD_ProDKin_1 | 106 | 112 | PF00069 | 0.676 |
MOD_ProDKin_1 | 113 | 119 | PF00069 | 0.605 |
MOD_ProDKin_1 | 143 | 149 | PF00069 | 0.729 |
MOD_ProDKin_1 | 213 | 219 | PF00069 | 0.425 |
MOD_ProDKin_1 | 244 | 250 | PF00069 | 0.670 |
MOD_ProDKin_1 | 99 | 105 | PF00069 | 0.733 |
MOD_SUMO_for_1 | 86 | 89 | PF00179 | 0.639 |
MOD_SUMO_rev_2 | 21 | 29 | PF00179 | 0.505 |
TRG_DiLeu_BaEn_2 | 342 | 348 | PF01217 | 0.691 |
TRG_DiLeu_BaLyEn_6 | 25 | 30 | PF01217 | 0.473 |
TRG_ENDOCYTIC_2 | 300 | 303 | PF00928 | 0.517 |
TRG_NLS_MonoCore_2 | 69 | 74 | PF00514 | 0.512 |
TRG_NLS_MonoExtC_3 | 70 | 75 | PF00514 | 0.670 |
TRG_NLS_MonoExtN_4 | 70 | 75 | PF00514 | 0.669 |
TRG_Pf-PMV_PEXEL_1 | 27 | 31 | PF00026 | 0.368 |
TRG_Pf-PMV_PEXEL_1 | 275 | 280 | PF00026 | 0.276 |
TRG_Pf-PMV_PEXEL_1 | 52 | 56 | PF00026 | 0.265 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC65 | Leptomonas seymouri | 60% | 98% |
A0A0S4KFK0 | Bodo saltans | 35% | 100% |
A0A1X0P199 | Trypanosomatidae | 34% | 100% |
A0A3R7KQ25 | Trypanosoma rangeli | 33% | 100% |
A3KMV2 | Bos taurus | 26% | 100% |
A4HIR8 | Leishmania braziliensis | 77% | 100% |
A4I614 | Leishmania infantum | 100% | 100% |
C9ZRD9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9B1A5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
O74803 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 25% | 100% |
P32628 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 100% |
P54725 | Homo sapiens | 27% | 100% |
P54726 | Mus musculus | 26% | 100% |
P54727 | Homo sapiens | 28% | 100% |
P54728 | Mus musculus | 27% | 100% |
Q29RK4 | Bos taurus | 25% | 100% |
Q40742 | Oryza sativa subsp. japonica | 27% | 100% |
Q4KMA2 | Rattus norvegicus | 27% | 100% |
Q4Q6V9 | Leishmania major | 91% | 100% |
Q84L30 | Arabidopsis thaliana | 28% | 100% |
Q84L31 | Arabidopsis thaliana | 27% | 100% |
Q84L32 | Arabidopsis thaliana | 27% | 100% |
Q84L33 | Arabidopsis thaliana | 27% | 100% |
V5B773 | Trypanosoma cruzi | 36% | 100% |